(Q46110651)

19 December 2017

title

Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria (English)

1 reference

19 December 2017

main subject

Clostridium difficile

0 references

author

Ellie J. C. Goldstein

5

Ellie J C Goldstein

1 reference

19 December 2017

Kerin L. Tyrrell

3

Kerin L Tyrrell

1 reference

19 December 2017

Diane M. Citron

1

Diane M Citron

1 reference

19 December 2017

C. Vreni Merriam

4

Vreni Merriam

1 reference

19 December 2017

Yumi A. Warren

2

Yumi A Warren

1 reference

19 December 2017

language of work or name

English

0 references

publication date

24 February 2009

1 reference

19 December 2017

Journal of Antimicrobial Chemotherapy

published in

1 reference

19 December 2017

volume

63

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

972-976

1 reference

19 December 2017

Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

Antianaerobic Antibiotic Therapy Promotes Overgrowth of Antibiotic-Resistant, Gram-Negative Bacilli and Vancomycin-Resistant Enterococci in the Stool of Colonized Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

21 January 2018

Colonization resistance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

Antibacterial activity of REP8839, a new antibiotic for topical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP037

21 January 2018

Identifiers

DOI

10.1093/JAC/DKP037

1 reference

19 December 2017

1 reference

19 December 2017